Target- |
Mechanism- |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
耳闭清颗粒治疗急性分泌性中耳炎(风热袭耳证)有效性和安全性的随机、双盲、剂量平行对照、多中心临床试验
[Translation] A randomized, double-blind, dose-controlled, multicenter clinical trial on the efficacy and safety of Erbiqing granules in the treatment of acute secretory otitis media (wind-heat attack on the ear syndrome)
初步评价耳闭清颗粒治疗急性分泌性中耳炎(风热袭耳证)的有效性与安全性,同时进行剂量探索,为Ⅲ期临床试验提供依据。
[Translation] To preliminarily evaluate the effectiveness and safety of Erbiqing Granules in the treatment of acute secretory otitis media (wind-heat attack on the ear syndrome), and conduct dose exploration to provide a basis for Phase III clinical trials.
100 Clinical Results associated with Anhui Jiuding Medical Technology Co., Ltd.
0 Patents (Medical) associated with Anhui Jiuding Medical Technology Co., Ltd.
100 Deals associated with Anhui Jiuding Medical Technology Co., Ltd.
100 Translational Medicine associated with Anhui Jiuding Medical Technology Co., Ltd.